Cited by 204Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine

Schlagenhauf, Florian, Juckel, Georg, Koslowski, Michael, Kahnt, Thorsten, Knutson, Brian, Dembler, Theresa, Kienast, Thorsten, Gallinat, Jürgen, Wrase, Jana, Heinz, Andreas·2008·Psychopharmacology

DOI 10.1007/s00213-007-1016-4

Open this paper in CoChat — free account

Abstract

Rationale High blockade of dopamine D2 receptors in the ventral striatum including the nucleus accumbens may interfere with reward anticipation and cause secondary negative symptoms such as apathy or anhedonia. This may not be the case with newer neuroleptics such as olanzapine, which show less dopamine D2 receptor blockade and a faster off-rate from the receptor.Objectives We used functional magnetic resonance imaging to assess the blood oxygenation level dependent response in the ventral striatum of schizophrenics medicated with typical neuroleptics (T1) and after switching them to olanzapine (T2) and of healthy control subjects at corresponding time points during reward anticipation.Materials and methods Ten schizophrenics, while medicated with typical neuroleptics (T1) and after having been switched to olanzapine (T2), and ten matched healthy volunteers participated in a monetary incentive delay task, in which visual cues predicted that a rapid response to a subsequent target stimulus would either result in monetary gain or have no consequence.Results During reward anticipation, healthy volunteers showed significantly higher ventral striatal activation compared to schizophrenic patients treated with typical neuroleptics but not olanzapine, which was reflected in a significant interaction between group and session. In patients treated with typical neuroleptics, but not with olanzapine, decreased left ventral striatal activation was correlated with negative symptoms.Conclusions Failure to activate the ventral striatum during reward anticipation was pharmacologically state-dependent and observed only in patients treated with typical neuroleptics but not with olanzapine, which may indicate that this drug did not induce secondary negative symptoms via interference with reward anticipation.

Integrity signals

Registry

Crossref · 10.1007/s00213-007-1016-4

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The assessment and analysis of handedness: The Edinburgh inventory
Oldfield, R. C. (1971) · Neuropsychologia · doi:10.1016/0028-3932(71)90067-4 · Cited by 35,900
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Statistical parametric maps in functional imaging: A general linear approach
Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology and pharmacology in schizophrenia
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens
Knutson, B., Adams, C. M., Fong, G. W., & Hommer, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-j0002.2001 · Cited by 2,244
Self-citation
Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans
Pessiglione, M., Seymour, B., Flandin, G., Dolan, R. J., & Frith, C. D. (2006) · Nature · doi:10.1038/nature05051 · Cited by 1,584
Untitled work
(1997) · American Psychiatric Press eBooks · Cited by 1,436
Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine
Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,420
Functional imaging of neural responses to expectancy and experience of monetary gains and losses
Breiter, H. C., Aharon, I., Kahneman, D., Dale, A., & Shizgal, P. (2001) · Neuron · doi:10.1016/s0896-6273(01)00303-8 · Cited by 1,404

Show all 48 references

Research works printed but not linked: 5

First M, Spitzer R, Gibbon M, Williams J (1997) Structured clinical interview for DSM-IV personality disorders, (SCID-II). American Psychiatric, Washington, DC
First MB, Spitzer RL, Gibbon M, Williams J (2001) Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition with psychotic screen (SCID-I/P W/ PSY SCREEN). New York State Psychiatric Institute, New York
Heaton R (1981) A manual for the Wisconsin Card Sorting Test. Psychological Assessment Resources, Odessa, Florida
Muller JL, Deuticke C, Putzhammer A, Roder CH, Hajak G, Winkler J (2003) Schizophrenia and Parkinson’s disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study. Psychiatry Clin Neurosci 57:562–568
Schmidt K, Metzler P (1992) Wortschatztest (WST). Beltz test, Weinheim

Sorted by citations

Items 101–200 of 204

The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description
Paterson, L. M., Flechais, R., Murphy, A., Reed, L. J., Abbott, S., Boyapati, V., Elliott, R., Erritzøe, D., Ersche, K. D., Faluyi, Y. O., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115596155 · Cited by 36
Functional dysconnectivity of the limbic loop of frontostriatal circuits in first‐episode, treatment‐naive schizophrenia
Lin, P., Wang, X., Zhang, B., Kirkpatrick, B. W., Öngür, D., Levitt, J. J., Jovicich, J., Yao, S., & Wang, X. (2017) · Human Brain Mapping · doi:10.1002/hbm.23879 · Cited by 35
Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls
Cassidy, C., Lepage, M., Harvey, P., & MALLA, A. K. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.02.028 · Cited by 36
Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer’s disease
van der Wee, N. J. A., Bilderbeck, A. C., Cabello, M., Ayuso‐Mateos, J. L., Saris, I. M. J., Giltay, E. J., Penninx, B. W. J. H., Arango, C., Post, A., & Porcelli, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.020 · Cited by 40
Impaired Cross-Talk between Mesolimbic Food Reward Processing and Metabolic Signaling Predicts Body Mass Index
Simon, J. J., Skunde, M., Sinno, M. H., Brockmeyer, T., Herpertz, S. C., Bendszus, M., Herzog, W., & Friederich, H. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00359 · Cited by 35
Dopaminergic modulation of the reward system in schizophrenia: A placebo-controlled dopamine depletion fMRI study
Alves, F. D. S., Bakker, G., Schmitz, N., Abeling, N. G. G. M., Hasler, G., van der Meer, J. N., Nederveen, A. J., de Haan, L., LINSZEN, D. H., & van Amelsvoort, T. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.06.008 · Cited by 38
Salience and psychosis: moving from theory to practise
Jensen, J., & Kapur, S. (2008) · Psychological Medicine · doi:10.1017/s0033291708003899 · Cited by 35
Reward-dependent modulation of working memory is associated with negative symptoms in schizophrenia
Hager, O. M., Kirschner, M., Bischof, M., Hartmann-Riemer, M. N., Kluge, A., Seifritz, E., Tobler, P. N., & Kaiser, S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.024 · Cited by 36
Mild Reinforcement Learning Deficits in Patients With First-Episode Psychosis
Chang, W. C., Waltz, J. A., Gold, J. M., Chan, T. C. W., & Chen, E. Y. H. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw060 · Cited by 37
Computational approaches to schizophrenia: A perspective on negative symptoms
Deserno, L., Heinz, A., & Schlagenhauf, F. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2016.10.004 · Cited by 31
Self-citation
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
Collo, G., Mucci, A., Giordano, G. M., Pich, E. M., & Galderisi, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00632 · Cited by 35
Emotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanisms
Anticevic, A., Schleifer, C., & Cho, Y. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/aanticevic · Cited by 34
Relationship Between Persistent Negative Symptoms and Findings of Neurocognition and Neuroimaging in Schizophrenia
İnce, E., & Üçok, A. (2017) · Clinical EEG and Neuroscience · doi:10.1177/1550059417746213 · Cited by 33
Neural, behavioural and real-life correlates of social context sensitivity and social reward learning during interpersonal interactions in the schizophrenia spectrum
Hanssen, E., van Buuren, M., van Atteveldt, N., Lemmers-Jansen, I. L. J., & Fett, A.-K. J. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211010327 · Cited by 33
Antipsychotic dose modulates behavioral and neural responses to feedback during reinforcement learning in schizophrenia
Insel, C., Reinen, J., Weber, J., Wager, T. D., Jarskog, L. F., Shohamy, D., & Smith, E. E. (2014) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-014-0261-3 · Cited by 35
Reduced brain reward response during cooperation in first-degree relatives of patients with psychosis: an fMRI study
Gromann, P. M., Shergill, S. S., de Haan, L., Meewis, D. G. J., Fett, A.-K. J., Korver‐Nieberg, N., & A, L. K. M. (2014) · Psychological Medicine · doi:10.1017/s0033291714000737 · Cited by 32
Rostral medial prefrontal dysfunctions and consummatory pleasure in schizophrenia: A meta-analysis of functional imaging studies
Yan, C., Yang, T., Yu, Q., Jin, Z. H., Cheung, E. F. C., Liu, X., & Chan, R. C. K. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.01.001 · Cited by 33
Impaired subjective well-being in schizophrenia is associated with reduced anterior cingulate activity during reward processing
Gilleen, J., Shergill, S. S., & Kapur, S. (2014) · Psychological Medicine · doi:10.1017/s0033291714001718 · Cited by 33
Prior Haloperidol, but not Olanzapine, Exposure Augments the Pursuit of Reward Cues: Implications for Substance Abuse in Schizophrenia
Bédard, A.-M., Maheux, J., Lévesque, D., & Samaha, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs077 · Cited by 30
Negative symptoms in schizophrenia are associated with aberrant striato-cortical connectivity in a rewarded perceptual decision-making task
Reckless, G. E., Andreassen, O. A., Server, A., Østefjells, T., & Jensen, J. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.04.025 · Cited by 28
Anticipatory pleasure for future rewards is attenuated in patients with schizophrenia but not in individuals with schizotypal traits
Yan, C., Lui, S. S. Y., Zou, L., Wang, C., Zhou, F., Cheung, E. F. C., Shum, D., & Chan, R. C. K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.003 · Cited by 32
The emerging biology of delusions
Murray, G. (2010) · Psychological Medicine · doi:10.1017/s0033291710000413 · Cited by 29
Functional connectivity and grey matter volume of the striatum in schizophrenia
Koch, K., Rus, O. G., Reeß, T. J., Schachtzabel, C., Wagner, G., Schultz, C. C., Sorg, C., & Schlösser, R. G. M. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.138099 · Cited by 29
Testosterone and reward prediction-errors in healthy men and men with schizophrenia
Morris, R. W., Purves-Tyson, T. D., Weickert, C. S., Rothmond, D. A., Lenroot, R., & Weickert, T. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.030 · Cited by 28
Neural correlates of reward processing in healthy siblings of patients with schizophrenia
Hanssen, E., van der Velde, J., Gromann, P. M., Shergill, S. S., de Haan, L., Bruggeman, R., Krabbendam, L., Aleman, A., & van Atteveldt, N. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00504 · Cited by 31
Predicting the future in schizophrenia: The discrepancy between anticipatory and consummatory pleasure
Edwards, C., Cella, M., Tarrier, N., & Wykes, T. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.091 · Cited by 26
Negative Symptoms and Reward Disturbances in Schizophrenia Before and After Antipsychotic Monotherapy
Nielsen, M. Ø., Rostrup, E., Broberg, B. V., Wulff, S., & Glenthoj, B. Y. (2017) · Clinical EEG and Neuroscience · doi:10.1177/1550059417744120 · Cited by 29
The neural mechanisms of social reward in early psychosis
Fett, A.-K. J., Mouchlianitis, E. D., Gromann, P. M., Vanes, L. D., Shergill, S. S., & A, L. K. M. (2019) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsz058 · Cited by 26
The longitudinal stability of fMRI activation during reward processing in adolescents and young adults
Baranger, D. A. A., Lindenmuth, M., Nance, M., Guyer, A. E., Keenan, K. E., Hipwell, A. E., Shaw, D. S., & Forbes, E. E. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.117872 · Cited by 26
Do Atypical Antipsychotics Really Enhance Smoking Reduction More Than Typical Ones?
Wu, B., Chen, H., & Lee, S.-M. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31828b2575 · Cited by 25
Inhibition of the reward system by antipsychotic treatment
Juckel, G. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.1/gjuckel · Cited by 25
Self-citation
Examination of affective and cognitive interference in schizophrenia and relation to symptoms.
Martin, E. A., Becker, T. M., Cicero, D. C., & Kerns, J. G. (2013) · Journal of Abnormal Psychology · doi:10.1037/a0033956 · Cited by 25
Effects of olanzapine during cognitive and emotional processing in schizophrenia: A review of functional magnetic resonance imaging findings
Fabro, L. D., Delvecchio, G., D’Agostino, A., & Brambilla, P. (2019) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2693 · Cited by 25
Reward modulates the mirror neuron system in schizophrenia: A study into the mu rhythm suppression, empathy, and mental state attribution
Brown, E. C., Gonzalez-Liencres, C., Taş, C., & Brüne, M. (2015) · Social Neuroscience · doi:10.1080/17470919.2015.1053982 · Cited by 22
The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description
McGonigle, J., Murphy, A., Paterson, L. M., Reed, L. J., Nestor, L. J., Nash, J., Elliott, R., Ersche, K. D., Flechais, R., Newbould, R. D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116668592 · Cited by 21
Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia
Koychev, I., Barkus, E., Ettinger, U., Killcross, S., Roiser, J. P., Wilkinson, L., & Deakin, B. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111414450 · Cited by 24
Investigating the empirical support for therapeutic targets proposed by the temporal experience of pleasure model in schizophrenia: A systematic review
Edwards, C., Cella, M., Tarrier, N., & Wykes, T. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.013 · Cited by 28
Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function
Hage, C. E., Bédard, A.-M., & Samaha, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.012 · Cited by 20
Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia
Whitton, A. E., Green, A. I., Pizzagalli, D. A., Roth, R. M., Williams, J. M., & Brunette, M. F. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby185 · Cited by 20
Schizophrenia and co-occurring substance use disorder: Reward, olfaction and clozapine
Mesholam‐Gately, R. I., Gibson, L. E., Seidman, L. J., & Green, A. I. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.002 · Cited by 20
Impaired prefrontal activity to regulate the intrinsic motivation-action link in schizophrenia
Takeda, K., Matsumoto, M., Ogata, Y., Maida, K., Murakami, H., Murayama, K., Shimoji, K., Hanakawa, T., Matsumoto, K., & Nakagome, K. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.07.003 · Cited by 20
Social Functioning and Age Across Affective and Nonaffective Psychoses
Martin, E. A., Öngür, D., Cohen, B. M., & Lewandowski, K. E. (2014) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000232 · Cited by 19
Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo
Sportelli, L., Eisenberg, D. P., Passiatore, R., D’Ambrosio, E., Antonucci, L. A., Bettina, J. S., Chen, Q., Goldman, A. L., Gregory, M. D., Griffiths, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47456-5 · Cited by 19
Neural basis of anhedonia as a failure to predict pleasantness in schizophrenia
Choi, S., Lee, H., Ku, J. H., Yoon, K. J., & Kim, J. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.819121 · Cited by 18
Neural substrates of motivational dysfunction across neuropsychiatric conditions: Evidence from meta-analysis and lesion network mapping
Feng, C., Huang, W., Xu, K., Stewart, J. L., Camilleri, J. A., Yang, X., Wei, P., Gu, R., Luo, W., & Eickhoff, S. B. (2022) · Clinical Psychology Review · doi:10.1016/j.cpr.2022.102189 · Cited by 19
Cerebral blood flow in striatal regions is associated with apathy in patients with schizophrenia
Schneider, K., Michels, L., Hartmann-Riemer, M. N., Burrer, A., Tobler, P. N., Stämpfli, P., Kirschner, M., Seifritz, E., & Kaiser, S. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170150 · Cited by 17
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study
Fervaha, G., Caravaggio, F., Mamo, D. C., Mulsant, B. H., Pollock, B. G., Nakajima, S., Gerretsen, P., Rajji, T. K., Mar, W., Iwata, Y., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4415-6 · Cited by 16
Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis
Borgan, F., O’Daly, O., Hoang, K., Veronese, M., Withers, D. J., Batterham, R. L., & Howes, O. D. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6893 · Cited by 16
Increased ventral striatal functional connectivity in patients with schizophrenia during reward anticipation
Carruzzo, F., Kaiser, S., Tobler, P. N., Kirschner, M., & Simon, J. J. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102944 · Cited by 15
The pathophysiological mechanisms of motivational deficits in Parkinson’s disease
Chagraoui, A., Boukhzar, L., Thibaut, F., Anouar, Y., & Maltête, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.022 · Cited by 15
The effect of risperidone on reward‐related brain activity is robust to drug‐induced vascular changes
Hawkins, P. C. T., Zelaya, F. O., O’Daly, O., Holiga, Š., Dukart, J., Umbricht, D., & Mehta, M. A. (2021) · Human Brain Mapping · doi:10.1002/hbm.25400 · Cited by 14
Functional Brain Imaging in Schizophrenia
Meyer‐Lindenberg, A., & Bullmore, E. T. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch17 · Cited by 16
Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients
Beninger, R. J., Baker, T. W., Florczynski, M. M., & Banasikowski, T. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9178-y · Cited by 14
Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D2 receptors in mouse striatum: relation to cannabinoid-1 (CB1) receptor targeting
Lane, D., Chan, J., Fitzgerald, M. L., Kearn, C. S., Mackie, K., & Pickel, V. M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2553-4 · Cited by 14
Effects of haloperidol and aripiprazole on the human mesolimbic motivational system: A pharmacological fMRI study
Bolstad, I., Andreassen, O. A., Groote, I. R., Server, A., Sjaastad, I., Kapur, S., & Jensen, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.016 · Cited by 13
Anterior internal capsule volumes increase in patients with schizophrenia switched from typical antipsychotics to olanzapine
Goghari, V., Lang, D. J., Khorram, B., Götz, J., Vandorpe, R. A., Smith, G. N., Kopala, L., Barr, A. M., & Honer, W. G. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110363314 · Cited by 13
Distinct patterns of dysfunctional appetitive and aversive motivation in bipolar disorder versus schizophrenia: An event-related potential study.
Horan, W. P., Wynn, J. K., Hajcak, G., Altshuler, L. L., & Green, M. F. (2016) · Journal of Abnormal Psychology · doi:10.1037/abn0000142 · Cited by 12
Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls
Vignapiano, A., Mucci, A., Merlotti, E., Giordano, G. M., Amodio, A., Palumbo, D., & Galderisi, S. (2017) · Clinical EEG and Neuroscience · doi:10.1177/1550059417745935 · Cited by 12
Cooperation and sensitivity to social feedback during group interactions in schizophrenia
Hanssen, E., Fett, A.-K. J., White, T. P., Caddy, C., Reimers, S. J., & Shergill, S. S. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.065 · Cited by 12
Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression
Lai, C. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.031 · Cited by 10
Neurofunctional view of psychiatry: clinical brain imaging revisited
Hendler, T., Bleich‐Cohen, M., & Sharon, H. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832a16f0 · Cited by 10
Predictive processing accounts of psychosis: bottom-up or top-down disruptions
Goodwin, I., Diederen, K. M. J., Hird, E., Weilnhammer, V. A., Garrido, M. I., & Knolle, F. (2026) · Nature Mental Health · doi:10.1038/s44220-025-00558-5 · Cited by 9
Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
Takeda, K., Sumiyoshi, T., Matsumoto, M., Murayama, K., Ikezawa, S., Matsumoto, K., & Nakagome, K. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00178 · Cited by 10
Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [11C]-carfentanil PET and fMRI study
Shatalina, E., Ashok, A. H., Wall, M. B., Nour, M. M., Myers, J., Marques, T. R., Rabiner, E. A., & Howes, O. D. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103481 · Cited by 8
Impaired reward responsiveness in schizophrenia
Taylor, N., Hollis, J. P., Corcoran, S., Gross, R. E., Cuthbert, B. N., Swails, L. W., & Duncan, E. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.057 · Cited by 8
Might the inability to feel pleasure (anhedonia) explain the symptoms of major depression and schizophrenia, including unmotivated anxiety, delusions and hallucinations?
Grillo, L. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.10.002 · Cited by 7
The effect of vortioxetine on anhedonia in patients with schizophrenia
Greš, A., Šagud, M., & Dickov, A. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231199925 · Cited by 7
Better Biomarkers, Faster Drugs, Stronger Models: Progress Towards Precision Psychiatry.
Siegel, J. S., Pearson, C., & Lenze, E. J. (2023) · PubMed Central · Cited by 5
Intact Differentiation of Responses to Socially-Relevant Emotional Stimuli Across Psychotic Disorders: An Event-Related Potential (ERP) StudyPreprint
Clayson, P. E., Wynn, J. K., Jimenez, A. M., Reavis, E. A., Lee, J., Green, M. F., & Horan, W. P. (2021) · doi:10.1016/j.schres.2022.06.033 · Cited by 6
Negative Symptoms Across the Schizophrenia Spectrum: Phenomenological and Neurobiological Perspectives
Foussias, G., Agid, O., & Remington, G. J. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_1 · Cited by 4
Future-Oriented Treatments for Suicide: An Overview of Three Modern Approaches
Yu, E. A., Cheavens, J. S., Vilhauer, J. S., & van Beek, W. (2018) · Advances in mental health and addiction · doi:10.1007/978-3-030-03225-8_9 · Cited by 4
Cigarette smoking modulates medication-associated deficits in a monetary reward task in patients with schizophrenia
Lernbass, B., Grön, G., Wolf, N. D., & Abler, B. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0370-3 · Cited by 5
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
Hawkins, P. C. T., Schwarz, A. J., Stone, J. M., Pepper, F., Gilleen, J., Gijsen, S. C. J., Mazibuko, N., Arkilo, D., Yin, W., Wu, J., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06884-x · Cited by 3
Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition
Dawson, G. R. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5016 · Cited by 4
Can Models of Reinforcement Learning Help Us to Understand Symptoms of Schizophrenia?
Murray, G. K., Tudor-Sfetea, C., & Fletcher, P. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805308-9.00021-x · Cited by 3
Do motivation deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of behavioural response to natural rewards and drug cues
Cassidy, C., Lepage, M., & MALLA, A. K. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.021 · Cited by 3
GABA and Schizophrenia
Kehne, J. H., & Maynard, G. D. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch15 · Cited by 3
Overestimating environmental volatility increases switching behavior and is linked to activation of dorsolateral prefrontal cortex in schizophrenia
Deserno, L., Boehme, R., Mathys, C. D., Katthagen, T., Kaminski, J. A., Stephan, K. E., Heinz, A., & Schlangenhauf, F. (2017) · Max Planck Digital Library · Cited by 2
Self-citation
Clinical response to treatment with a partial dopamine agonist is related to changes in reward processing
Tangmose, K., Rostrup, E., Bojesen, K. B., Sigvard, A. K., Glenthoj, B. Y., & Nielsen, M. Ø. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115308 · Cited by 5
Lernen und Belohnungssystem
Rademacher, L., & Spreckelmeyer, K. N. (2013) · Springer eBooks · doi:10.1007/978-3-642-29800-4_25 · Cited by 2
Olanzapine, blonanserin, and aripiprazole associated with different frontostriatal reward system activation in patients with schizophrenia
Hashimoto, N., Toyomaki, A., Miyamoto, T., MIYAZAKI, A., & Kuksumi, I. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.11.035 · Cited by 2
Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity
Fish, S., Christidi, F., Karavasilis, E., Velonakis, G., Kelekis, N., Klein, C., Stefanis, N. C., & Smyrnis, N. (2021) · Schizophrenia · doi:10.1038/s41537-021-00163-2 · Cited by 13
Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients
Beninger, R. J., Baker, T. W., Florczynski, M. M., & Banasikowski, T. J. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_1 · Cited by 2
Theory of Mind and Social Functioning in Health and Psychopathology: A Social Neuroscience Perspective
Dodell‐Feder, D. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 2
Schizophrenia Patients Show Largely Similar Salience Signaling Compared to Healthy Controls in an Observational Task Environment
Culbreth, A. J., Kasanova, Z., Ross, T. J., Salmeron, B. J., Gold, J. M., Stein, E. A., & Waltz, J. A. (2021) · Brain Sciences · doi:10.3390/brainsci11121610 · Cited by 1
fMRI Investigations of the Mesolimbic Dopaminergic Reward System in Schizophrenia
Juckel, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-54542-9_12 · Cited by 1
Self-citation
Glutamatergic Approaches for the Treatment of Schizophrenia
Morrow, J. A., Gilfillan, R. F., & Neale, S. A. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00056 · Cited by 1
Reward Processing in Motivational and Affective Disorders
Skandali, N. (2016) · Frontiers research topics · doi:10.3389/978-2-88919-986-0 · Cited by 1
Functional connectivity in a monetary and social incentive delay task in medicated patients with schizophrenia
Hanewald, B., Lockhofen, D. E. L., Sammer, G., Stingl, M., Gallhofer, B., Mulert, C., & Iffland, J. R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1200860 · Cited by 2
Geschlechtsspezifische Aspekte von Belohnungsantizipation : Geschlechtsspezifische Unterschiede im belohnungsorientierten Verhalten: Neuronale Grundlage und klinische Relevanz
Rademacher, L., Spreckelmeyer, K. N., Krach, S., Gründer, G., & Einleitung, Ñ. (2010) · RWTH Publications (RWTH Aachen) · Cited by 1
Untersuchungen zum endogenen Reward-System unter Therapie von atypischen und klassischen Antipsychotika
Juckel, G., Schlagenhauf, F., & Heinz, A. (2010) · Springer eBooks · doi:10.1007/978-3-211-92215-6_11 · Cited by 1
Self-citation
Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal functionPreprint
Sportelli, L., Eisenberg, D. P., Passiatore, R., D’Ambrosio, E., Antonucci, L. A., Chen, Q., Czarapata, J., Goldman, A. L., Gregory, M. A., Griffiths, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.20.558594 · Cited by 1
Étude du rôle de la dopamine et de la sérotonine dans l’effet atténuateur des antipsychotiques et de l’OSU-6162 sur la récompense induite par la stimulation du faisceau médian prosencéphalique chez le rongeur
Benaliouad, F. (2009) · doi:10.71781/30069
Schizophrenia and comorbid cannabis use disorders. Brain structure, function and the effect of antipsychotic medications
Machielsen, M. W. J. (2014) · UvA-DARE (University of Amsterdam)
FMRI investigation of intertemporal discounting in schizophrenia
Avsar, K. B. (2012) · ProQuest Demo Repository
Investigations Of The Determinants of Functional Outcomes In Schizophrenia: Cross-sectional And Longitudinal Examinations Of The Role Of Negative Symptoms
Foussias, G. (2013) · TSpace (University of Toronto)
Functional neuroimaging of pathophysiological mesolimbic dopamine system and aberrant motivational salience in schizophrenia
Richter, A. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6346
P.484 Preliminary fMRI results exploring processing of monetary and social rewards in schizophrenia, Alzheimer's disease, and healthy controls
Raslescu, A., Malik, A. S., Clark, J., Bilderbeck, A. C., Hayen, A., Dawson, G. R., Penninx, B. W. J. H., Arango, C., van der Wee, N. J. A., Rossum, I. W.-V., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.492
Can models of reinforcement learning help us to understand symptoms of schizophrenia?
Murray, G. K., & Fletcher, P. C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374620-7.00011-x
Current awareness in human psychopharmacology
(2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.892

Authors: Schlagenhauf, F., Juckel, G., Koslowski, M., Kahnt, T., Knutson, B., Dembler, T., Kienast, T., Gallinat, J., Wrase, J., & Heinz, A.
Affiliations: Stiftung Charité (DE)
Charité – Universitätsmedizin Berlin (DE)
Stanford University (US)
Corresponding author: Heinz, Andreas
ORCID: Schlagenhauf, Florian
Juckel, Georg
Koslowski, Michael
Kahnt, Thorsten
Knutson, Brian
Gallinat, Jürgen
Heinz, Andreas
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2007-12-21
Volume: 196
Issue: 4
Pages: 673-684
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-007-1016-4
OpenAlex: W2153437292
Cited by: 204
References: 48
Citations by year: 2026: 2 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 4 · 2019: 10 · 2018: 12 · 2017: 14 · 2016: 20 · 2015: 22 · 2014: 19 · 2013: 18 · 2012: 17
FWCI: 6.46
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords: schizophrenia, olanzapine, typical antipsychotics, reward anticipation, ventral striatum, nucleus accumbens, dopamine D2 receptor blockade, negative symptoms, anhedonia, apathy, monetary incentive delay task, antipsychotic switching, functional MRI
MeSH terms: Olanzapine, Adult, Analysis of Variance, Benzodiazepines, Female, Flupenthixol, Fluphenazine, Haloperidol, Humans, Magnetic Resonance Imaging, Male, Motivation, Nucleus Accumbens, Oxygen, Psychomotor Performance, Reaction Time, Reward, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents, Neostriatum, Receptors, Dopamine D2, Dopamine D2 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks